dr-emily-colvin

Dr Emily Colvin, Postdoctoral Fellow at The Bill Walsh Translational Cancer Research Lab, Kolling Institute, completed a BMedSc with First Class Honours in Physiology in 2005. In 2006 she was awarded an Australian Postgraduate Award and commenced her PhD in the Pancreatic Cancer Group at the Garvan Institute which focused on investigating aberrations in embryonic signalling pathways in pancreatic cancer.

Her PhD work involved validating biomarkers of potential clinical use in large cohorts of pancreatic cancer patients, this contributed to a publication in the journal Gastroenterology. During her PhD, she also collaborated on several other projects with researchers and clinicians from the Pancreatic Cancer Group as well as researchers from the Victor Chang Cardiac Research Institute resulting in twelve publications, including Nature, the Journal of Clinical Oncology, and Cell Stem Cell.

Dr Colvin was awarded a Research Scholar Award from the Cancer Institute NSW (CINSW) in 2007 and then in 2009 received the NSW Premier’s Award for Outstanding Cancer Research Scholar of the Year. After completing her PhD, in 2011 she commenced her first postdoctoral position in the Hormones and Cancer Division of the Kolling Institute, University of Sydney. Emily successfully obtained her first independent research grant as an early career scientist from University of Sydney with the aim to investigate the role of the tumour microenvironment in ovarian cancer. In 2012, she then went on to receive a CINSW Early Career Researcher Fellowship as well as a project grant from the Cure Cancer Australia Foundation co-funded with Cancer Australia as part of the Priority Driven Collaborative Cancer Research Scheme.

 

Research Interests

Investigating ovarian cancer progression for prognosis & novel therapies

“Investigating the role of cancer-associated fibroblasts in ovarian cancer”

University of Sydney Early Career Researcher Scheme 2012

“Investigating the tumour-promoting phenotype of cancer-associated fibroblasts in serous epithelial ovarian cancer”

Cure Cancer Australia Foundation and Cancer Australia PdCCRS grant 2013

“Characterising the tumour microenvironment of epithelial ovarian cancer”

Cancer Institute NSW Early Career Fellowship 2013

“The Rambo Study – fighting lung cancer with science”

Ramsey Project 2015                                                             

Year Award Institution
2009 Travel Award Garvan Institute
2009 NSW Cancer Institute Premier’s Award for Outstanding Cancer Research Scholar Cancer Institute NSW
2008 Travel Award American Pancreatic Association
2007 Travel Award American Pancreatic Association
2007 Research Scholar Award Cancer Institute NSW
2006 Australian Postgraduate Award
2006 Rising Star Award UNSW Faculty of Medicine
2005 Finalist, Tow Prize Prince of Wales Clinical School

Nahm, C., Brown, K., Townend, P., Colvin, E., Howell, V., Gill, A., Connor, S., Samra, J., Mittal, A. (2018). Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula. HPB, 20(5), 432-440. [More Information]

Pham, B., Colvin, E., Pham, T., Kim, B., Fuller, E., Moon, E., Barbey, R., Yuen, S., Rickman, B., Bryce, N., Howell, V., Hawkett, B., et al (2018). Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. International Journal of Molecular Sciences, 19(1), 205. [More Information]

Vafaee, F., Colvin, E., Mok, S., Howell, V., Samimi, G. (2017). Functional prediction of long non-coding RNAs in ovarian cancer-Associated fibroblasts indicate a potential role in metastasis. Scientific Reports, 7(1), 1-11. [More Information]

Hudson, A., Colvin, E. (2016). Transgenic mouse models of SV40-induced cancer. ILAR Journal, 57(1), 44-54. [More Information]

Moran-Jones, K., Gloss, B., Murali, R., Chang, D., Colvin, E., Jones, M., Yuen, S., Howell, V., Brown, L., Wong, C., et al (2015). Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer. Oncotarget, 6(42), 44551-44562. [More Information]

Upton, D., Fuller, E., Colvin, E., Walters, K., Jimenez, M., Desai, R., Handelsman, D., Howell, V., Allan, C. (2015). Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors. Hormones and Cancer, 6(4), 142-152. [More Information]

Cho, A., Howell, V., Colvin, E. (2015). The extracellular matrix in epithelial ovarian cancer – A piece of a puzzle. Frontiers in Oncology, 5, 1-16. [More Information]

Howell, V., Colvin, E. (2014). Genetically Engineered Insertional Mutagenesis in Mice to Model Cancer: Sleeping Beauty. In Shree Ram Singh, Vincenzo Coppola (Eds.), Mouse Genetics: Methods and Protocols, (pp. 367-383). New York: Springer. [More Information]

Colvin, E., Scarlett, C. (2014). A historical perspective of pancreatic cancer mouse models. Seminars in Cell & Developmental Biology, 27, 96-105. [More Information]

Colvin, E., Weir, C., Ikin, R., Hudson, A. (2014). SV40 TAg mouse models of cancer. Seminars in Cell & Developmental Biology, 27, 61-73. [More Information]

Colvin, E. (2014). Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Frontiers in Oncology, 4, 1-6. [More Information]

Colvin, E., Chang, D., Merrett, N., Biankin, A. (2008). Individualizing therapy for pancreatic cancer. Journal of Gastroenterology and Hepatology, 23(12), 1779-82. [More Information]

 

For more information please contact:

Phone: +61 2 9926 4846

Email: emily.colvin@sydney.edu.au

Find out more ..